C反応性タンパク質検査市場：アッセイタイプ、疾患領域、検出範囲、エンドユーザー別-世界予測2025-2030年

C反応性タンパク質検査市場は、2023年に15億米ドルと評価され、2024年には16億9,000万米ドルに達すると予測され、CAGR 12.41％で成長し、2030年には34億2,000万米ドルに達すると予測されています。

C反応性蛋白（CRP）検査は、体内の炎症や感染症の評価に使用される極めて重要な診断ツールであり、心血管疾患、感染症、慢性炎症性疾患などの状態を示す重要なマーカーです。CRP検査の重要性は、関節リウマチ、ループス、敗血症などの病態の診断とモニタリングにおいて臨床医を支援し、様々なヘルスケア環境に適用されることにあります。最終用途の範囲は、病院、診断研究所、学術研究機関、在宅医療の現場にまで及ぶ。慢性疾患の有病率の上昇、予防ヘルスケアに対する需要の増加、バイオテクノロジーの進歩は、この市場の成長を促進する主な要因です。特に高感度CRP測定法における技術の進歩は、診断の正確性と迅速性を高める機会を提供しています。個別化医療へのシフトと予防ヘルスケアの重視の高まりは、さらなる成長の道を提供します。しかし市場は、装置の高コスト、規制の複雑さ、炎症を示す代替バイオマーカーの利用可能性などの課題に直面しています。さらに、標準化が不十分なためCRP検査結果にばらつきがあることも懸念材料となっています。ビジネスチャンスを生かすには、コスト効率の高い迅速なポイントオブケア検査ソリューションの開発、検査法の標準化、検査解釈を強化するための高度なデータ解析の統合などのイノベーションに注力すべきです。さらに、予防医療におけるCRP検査の利点に関する認識と教育の拡大が、採用率を押し上げる可能性があります。市場競争は世界的・地域的に激化しており、市場の関連性を維持するためには継続的な研究開発と戦略的提携が必要です。最終的には、アッセイ感度と特異度の向上を追求するとともに、世界の認知度の向上とサプライチェーンの合理化に向けた取り組みが、既存の限界を克服し、特に新興市場において潜在的な成長地域を開拓する上で極めて重要となります。

市場力学：急速に進化するC反応性タンパク質検査市場の主要市場インサイトを公開

C反応性タンパク質検査市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 様々な健康状態に起因する炎症を測定する必要性
  • 慢性疾患の罹患率の上昇と老年人口の増加
  • 抗生物質を安全に減量するためのC反応性タンパク質ポイントオブケア検査の改善
• 市場抑制要因
  • C反応性タンパク質検査の有効性と特異性に関する問題
• 市場機会
  • 従来のCRP検査に関する技術の進歩
  • 犬の消化器疾患におけるCRPの調査
• 市場の課題
  • 検査技術や製品に対する厳しい承認プロセス

ポーターの5つの力：C反応性タンパク質検査市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：C反応性タンパク質検査市場における外部からの影響の把握

外部マクロ環境要因は、C反応性タンパク質検査市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析C反応性タンパク質検査市場における競合情勢の把握

C反応性タンパク質検査市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスC反応性タンパク質検査市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、C反応性タンパク質検査市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨C反応性タンパク質検査市場における成功への道筋を描く

C反応性タンパク質検査市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報に基づいた意思決定を行う上で役立つ重要な質問にも回答しています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • さまざまな健康状態によって引き起こされる炎症を測定する必要性
    • 慢性疾患の発症率の上昇と高齢者人口の増加
    • 抗生物質の安全な使用を減らすためのC反応性タンパク質の現場検査の改善
  • 抑制要因
    • C反応性タンパク質検査の有効性と特異性に関連する問題
  • 機会
    • 従来のCRP検査に関する技術的進歩
    • 犬の消化器疾患におけるC反応性タンパク質の調査
  • 課題
    • 試験技術と製品の厳格な承認プロセス
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 C反応性タンパク質検査市場アッセイタイプ別

• 化学発光免疫測定法
  • 遊離T3
  • 遊離T4
  • 甲状腺刺激ホルモン値
• エリサ
  • 臨床
  • 非臨床
• 免疫比濁法
• 放射免疫測定
  • 甲状腺刺激ホルモン受容体に対する自己抗体
  • ヒト血清甲状腺グロブリン自己抗体
  • 甲状腺ペルオキシダーゼ自己抗体

第7章 C反応性タンパク質検査市場疾患領域別

• がん
• 心血管疾患
• 子宮内膜症
• 炎症性腸疾患
• ループス
• 関節リウマチ

第8章 C反応性タンパク質検査市場検出範囲別

• 慢性CRP
• 従来のCRP
• hs-CRP

第9章 C反応性タンパク質検査市場：エンドユーザー別

• 介護付き生活ヘルスケア施設
• クリニック
• 病院
• 研究所

第10章 南北アメリカのC反応性タンパク質検査市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のC反応性タンパク質検査市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのC反応性タンパク質検査市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Abcam PLC
• Alere Inc.
• BIOMERIEUX
• BODITECH MED, Inc.
• CTK Biotech Inc.
• Danaher Corporation
• DiaSorin S.p.A.
• Eurolyser Diagnostica GmbH
• F. Hoffmann-La Roche Ltd.
• Fujifilm Corporation
• Getein Biotech, Inc.
• HORIBA, Ltd.
• Laboratory Corporation of America Holdings（LabCorp）
• Lumiradx Healthcare Private Limited
• Merck KGaA
• Ortho Clinical Diagnostics
• Quest Diagnostics Incorporated
• Randox Laboratories Ltd.
• SD Biosensor, Inc.
• Sekisui Diagnostics
• Siemens Healthineers AG
• Thermo Fisher Scientific, Inc.
• Trinity Biotech PLC
• Zoetis Inc.

LIST OF FIGURES

• FIGURE 1. C-REACTIVE PROTEIN TESTING MARKET RESEARCH PROCESS
• FIGURE 2. C-REACTIVE PROTEIN TESTING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. C-REACTIVE PROTEIN TESTING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. C-REACTIVE PROTEIN TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. C-REACTIVE PROTEIN TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. C-REACTIVE PROTEIN TESTING MARKET DYNAMICS
• TABLE 7. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY FREE T3, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY FREE T4, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY THYROTROPIN LEVELS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY NONCLINICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY IMMUNOTURBIDIMETRIC ASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY AUTOANTIBODIES AGAINST THYROTROPIN RECEPTOR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY HUMAN SERUM THYROGLOBULIN AUTOANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY THYROPEROXIDASE AUTOANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENDOMETRIOSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY LUPUS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CCRP, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CONVENTIONAL CRP, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY HS-CRP, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSISTED LIVING HEALTHCARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
• TABLE 45. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 49. ARGENTINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
• TABLE 50. ARGENTINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 51. ARGENTINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 52. ARGENTINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
• TABLE 53. ARGENTINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. BRAZIL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. BRAZIL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 56. BRAZIL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
• TABLE 57. BRAZIL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 58. BRAZIL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 59. BRAZIL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
• TABLE 60. BRAZIL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. CANADA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. CANADA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 63. CANADA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
• TABLE 64. CANADA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 65. CANADA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 66. CANADA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
• TABLE 67. CANADA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. MEXICO C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. MEXICO C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 70. MEXICO C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
• TABLE 71. MEXICO C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 72. MEXICO C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 73. MEXICO C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
• TABLE 74. MEXICO C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 77. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
• TABLE 78. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 79. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 80. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
• TABLE 81. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 83. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 85. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
• TABLE 86. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 87. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 88. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
• TABLE 89. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 91. AUSTRALIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. AUSTRALIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 93. AUSTRALIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
• TABLE 94. AUSTRALIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 95. AUSTRALIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 96. AUSTRALIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
• TABLE 97. AUSTRALIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. CHINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. CHINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 100. CHINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
• TABLE 101. CHINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 102. CHINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 103. CHINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
• TABLE 104. CHINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. INDIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 106. INDIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 107. INDIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
• TABLE 108. INDIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 109. INDIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 110. INDIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
• TABLE 111. INDIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. INDONESIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 113. INDONESIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 114. INDONESIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
• TABLE 115. INDONESIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 116. INDONESIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 117. INDONESIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
• TABLE 118. INDONESIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. JAPAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. JAPAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 121. JAPAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
• TABLE 122. JAPAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 123. JAPAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 124. JAPAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
• TABLE 125. JAPAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. MALAYSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 127. MALAYSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 128. MALAYSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
• TABLE 129. MALAYSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 130. MALAYSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 131. MALAYSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
• TABLE 132. MALAYSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. PHILIPPINES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 134. PHILIPPINES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 135. PHILIPPINES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
• TABLE 136. PHILIPPINES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 137. PHILIPPINES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 138. PHILIPPINES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
• TABLE 139. PHILIPPINES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. SINGAPORE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. SINGAPORE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 142. SINGAPORE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
• TABLE 143. SINGAPORE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 144. SINGAPORE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 145. SINGAPORE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
• TABLE 146. SINGAPORE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. SOUTH KOREA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 148. SOUTH KOREA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 149. SOUTH KOREA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
• TABLE 150. SOUTH KOREA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 151. SOUTH KOREA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 152. SOUTH KOREA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
• TABLE 153. SOUTH KOREA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 154. TAIWAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 155. TAIWAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 156. TAIWAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
• TABLE 157. TAIWAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 158. TAIWAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 159. TAIWAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
• TABLE 160. TAIWAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 161. THAILAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 162. THAILAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 163. THAILAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
• TABLE 164. THAILAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 165. THAILAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 166. THAILAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
• TABLE 167. THAILAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 168. VIETNAM C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 169. VIETNAM C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 170. VIETNAM C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
• TABLE 171. VIETNAM C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 172. VIETNAM C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 173. VIETNAM C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
• TABLE 174. VIETNAM C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 175. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 176. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 177. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
• TABLE 178. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 179. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 180. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
• TABLE 181. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 182. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 183. DENMARK C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 184. DENMARK C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 185. DENMARK C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
• TABLE 186. DENMARK C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 187. DENMARK C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 188. DENMARK C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
• TABLE 189. DENMARK C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 190. EGYPT C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 191. EGYPT C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 192. EGYPT C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
• TABLE 193. EGYPT C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 194. EGYPT C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 195. EGYPT C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
• TABLE 196. EGYPT C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 197. FINLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 198. FINLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 199. FINLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
• TABLE 200. FINLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 201. FINLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 202. FINLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
• TABLE 203. FINLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 204. FRANCE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 205. FRANCE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 206. FRANCE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
• TABLE 207. FRANCE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 208. FRANCE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 209. FRANCE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
• TABLE 210. FRANCE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 211. GERMANY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 212. GERMANY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 213. GERMANY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
• TABLE 214. GERMANY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 215. GERMANY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 216. GERMANY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
• TABLE 217. GERMANY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 218. ISRAEL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 219. ISRAEL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 220. ISRAEL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
• TABLE 221. ISRAEL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 222. ISRAEL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 223. ISRAEL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
• TABLE 224. ISRAEL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 225. ITALY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 226. ITALY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 227. ITALY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
• TABLE 228. ITALY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 229. ITALY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 230. ITALY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
• TABLE 231. ITALY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 232. NETHERLANDS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 233. NETHERLANDS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 234. NETHERLANDS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
• TABLE 235. NETHERLANDS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 236. NETHERLANDS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 237. NETHERLANDS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
• TABLE 238. NETHERLANDS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 239. NIGERIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 240. NIGERIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 241. NIGERIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
• TABLE 242. NIGERIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 243. NIGERIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 244. NIGERIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
• TABLE 245. NIGERIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 246. NORWAY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 247. NORWAY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 248. NORWAY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
• TABLE 249. NORWAY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 250. NORWAY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 251. NORWAY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
• TABLE 252. NORWAY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 253. POLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 254. POLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 255. POLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
• TABLE 256. POLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 257. POLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 258. POLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
• TABLE 259. POLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 260. QATAR C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 261. QATAR C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 262. QATAR C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
• TABLE 263. QATAR C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 264. QATAR C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 265. QATAR C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
• TABLE 266. QATAR C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 267. RUSSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 268. RUSSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 269. RUSSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
• TABLE 270. RUSSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 271. RUSSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 272. RUSSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
• TABLE 273. RUSSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 274. SAUDI ARABIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 275. SAUDI ARABIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 276. SAUDI ARABIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
• TABLE 277. SAUDI ARABIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 278. SAUDI ARABIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 279. SAUDI ARABIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
• TABLE 280. SAUDI ARABIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 281. SOUTH AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 282. SOUTH AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 283. SOUTH AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
• TABLE 284. SOUTH AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 285. SOUTH AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 286. SOUTH AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
• TABLE 287. SOUTH AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 288. SPAIN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 289. SPAIN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 290. SPAIN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
• TABLE 291. SPAIN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 292. SPAIN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 293. SPAIN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
• TABLE 294. SPAIN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 295. SWEDEN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 296. SWEDEN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 297. SWEDEN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
• TABLE 298. SWEDEN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 299. SWEDEN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 300. SWEDEN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
• TABLE 301. SWEDEN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 302. SWITZERLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 303. SWITZERLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 304. SWITZERLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
• TABLE 305. SWITZERLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 306. SWITZERLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 307. SWITZERLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
• TABLE 308. SWITZERLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 309. TURKEY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 310. TURKEY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 311. TURKEY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
• TABLE 312. TURKEY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 313. TURKEY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 314. TURKEY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
• TABLE 315. TURKEY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 316. UNITED ARAB EMIRATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 317. UNITED ARAB EMIRATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
• TABLE 318. UNITED ARAB EMIRATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
• TABLE 319. UNITED ARAB EMIRATES C-REACTIVE PROTEIN T

The C-Reactive Protein Testing Market was valued at USD 1.50 billion in 2023, expected to reach USD 1.69 billion in 2024, and is projected to grow at a CAGR of 12.41%, to USD 3.42 billion by 2030.

C-Reactive Protein (CRP) Testing is a pivotal diagnostic tool used for assessing inflammation or infection in the body, an essential marker indicating conditions like cardiovascular diseases, infections, and chronic inflammatory diseases. The importance of CRP testing lies in its application across various healthcare settings, aiding clinicians in diagnosing and monitoring conditions such as rheumatoid arthritis, lupus, and sepsis, among others. The end-use scope spans hospitals, diagnostic laboratories, academic and research institutions, and home care settings. The rising prevalence of chronic diseases, increasing demand for preventive healthcare, and advances in biotechnology are key factors fueling the growth of this market. Technological advancements, particularly in high-sensitivity CRP assays, present opportunities to enhance diagnostic accuracy and speed. The shift towards personalized medicine and the growing emphasis on preventive healthcare offer additional growth avenues. However, the market faces challenges such as the high cost of equipment, regulatory complexities, and the availability of alternative biomarkers that can also indicate inflammation. Additionally, variability in CRP test results due to poor standardization remains a concern. To capitalize on opportunities, businesses should focus on innovations like developing cost-effective, rapid, point-of-care testing solutions, achieving standardization in assays, and integrating advanced data analytics to enhance test interpretations. Furthermore, expanding awareness and education regarding the benefits of CRP testing in preventive health can drive adoption rates. The market is competitive with numerous global and regional players, necessitating continuous research and development (R&D) and strategic partnerships to maintain market relevance. Ultimately, the pursuit of improving assay sensitivity and specificity, along with initiatives for global awareness and streamlined supply chains, will be crucial in overcoming existing limitations and tapping into potential growth regions, especially in emerging markets.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving C-Reactive Protein Testing Market

The C-Reactive Protein Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Need to measure inflammation caused by a wide variety of health conditions
  • Rising incidence of chronic disorders and growing geriatric population
  • Improvements in C-reactive protein point-of-care testing for safely reducing antibiotic
• Market Restraints
  • Issues associated with efficacy and specificity of C-Reactive protein testing
• Market Opportunities
  • Technological advancements pertaining to conventional CRP tests
  • Research on C-reactive protein in gastrointestinal diseases of dogs
• Market Challenges
  • Stringent approval processes for testing techniques and products

Porter's Five Forces: A Strategic Tool for Navigating the C-Reactive Protein Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the C-Reactive Protein Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the C-Reactive Protein Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the C-Reactive Protein Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the C-Reactive Protein Testing Market

A detailed market share analysis in the C-Reactive Protein Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the C-Reactive Protein Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the C-Reactive Protein Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the C-Reactive Protein Testing Market

A strategic analysis of the C-Reactive Protein Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the C-Reactive Protein Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abcam PLC, Alere Inc., BIOMERIEUX, BODITECH MED, Inc., CTK Biotech Inc., Danaher Corporation, DiaSorin S.p.A., Eurolyser Diagnostica GmbH, F. Hoffmann-La Roche Ltd., Fujifilm Corporation, Getein Biotech, Inc., HORIBA, Ltd., Laboratory Corporation of America Holdings (LabCorp), Lumiradx Healthcare Private Limited, Merck KGaA, Ortho Clinical Diagnostics, Quest Diagnostics Incorporated, Randox Laboratories Ltd., SD Biosensor, Inc., Sekisui Diagnostics, Siemens Healthineers AG, Thermo Fisher Scientific, Inc., Trinity Biotech PLC, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the C-Reactive Protein Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Assay Type, market is studied across Chemiluminescence Immunoassay, ELISA, Immunoturbidimetric Assay, and Radioimmunoassay. The Chemiluminescence Immunoassay is further studied across Free T3, Free T4, and Thyrotropin Levels. The ELISA is further studied across Clinical and Nonclinical. The Radioimmunoassay is further studied across Autoantibodies Against Thyrotropin Receptor, Human Serum Thyroglobulin Autoantibodies, and Thyroperoxidase Autoantibodies.
• Based on Disease Area, market is studied across Cancer, Cardiovascular Diseases, Endometriosis, Inflammatory Bowel Disease, Lupus, and Rheumatoid Arthritis.
• Based on Detection Range, market is studied across cCRP, Conventional CRP, and hs-CRP.
• Based on End-User, market is studied across Assisted Living Healthcare Facilities, Clinics, Hospitals, and Laboratories.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Need to measure inflammation caused by a wide variety of health conditions
    • 5.1.1.2. Rising incidence of chronic disorders and growing geriatric population
    • 5.1.1.3. Improvements in C-reactive protein point-of-care testing for safely reducing antibiotic
  • 5.1.2. Restraints
    • 5.1.2.1. Issues associated with efficacy and specificity of C-Reactive protein testing
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements pertaining to conventional CRP tests
    • 5.1.3.2. Research on C-reactive protein in gastrointestinal diseases of dogs
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent approval processes for testing techniques and products
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. C-Reactive Protein Testing Market, by Assay Type

• 6.1. Introduction
• 6.2. Chemiluminescence Immunoassay
  • 6.2.1. Free T3
  • 6.2.2. Free T4
  • 6.2.3. Thyrotropin Levels
• 6.3. ELISA
  • 6.3.1. Clinical
  • 6.3.2. Nonclinical
• 6.4. Immunoturbidimetric Assay
• 6.5. Radioimmunoassay
  • 6.5.1. Autoantibodies Against Thyrotropin Receptor
  • 6.5.2. Human Serum Thyroglobulin Autoantibodies
  • 6.5.3. Thyroperoxidase Autoantibodies

7. C-Reactive Protein Testing Market, by Disease Area

• 7.1. Introduction
• 7.2. Cancer
• 7.3. Cardiovascular Diseases
• 7.4. Endometriosis
• 7.5. Inflammatory Bowel Disease
• 7.6. Lupus
• 7.7. Rheumatoid Arthritis

8. C-Reactive Protein Testing Market, by Detection Range

• 8.1. Introduction
• 8.2. cCRP
• 8.3. Conventional CRP
• 8.4. hs-CRP

9. C-Reactive Protein Testing Market, by End-User

• 9.1. Introduction
• 9.2. Assisted Living Healthcare Facilities
• 9.3. Clinics
• 9.4. Hospitals
• 9.5. Laboratories

10. Americas C-Reactive Protein Testing Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific C-Reactive Protein Testing Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa C-Reactive Protein Testing Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Abcam PLC
• 3. Alere Inc.
• 4. BIOMERIEUX
• 5. BODITECH MED, Inc.
• 6. CTK Biotech Inc.
• 7. Danaher Corporation
• 8. DiaSorin S.p.A.
• 9. Eurolyser Diagnostica GmbH
• 10. F. Hoffmann-La Roche Ltd.
• 11. Fujifilm Corporation
• 12. Getein Biotech, Inc.
• 13. HORIBA, Ltd.
• 14. Laboratory Corporation of America Holdings (LabCorp)
• 15. Lumiradx Healthcare Private Limited
• 16. Merck KGaA
• 17. Ortho Clinical Diagnostics
• 18. Quest Diagnostics Incorporated
• 19. Randox Laboratories Ltd.
• 20. SD Biosensor, Inc.
• 21. Sekisui Diagnostics
• 22. Siemens Healthineers AG
• 23. Thermo Fisher Scientific, Inc.
• 24. Trinity Biotech PLC
• 25. Zoetis Inc.